SCHEMBL14796196

SCHEMBL14796196

COc1ccc(Sc2cccc3[nH]c(=O)c(-c4nc5ccccc5[nH]4)c(N)c23)cc1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 14/20 0.52
PDGFRB P09619 10/20 0.52
KDR P35968 9/20 0.52
FLT1 P17948 6/20 0.52
CHEK1 O14757 1/20 0.52
TYMS P04818 3/20 0.52
EGFR P00533 1/20 0.52
DHFR P00374 1/20 0.49
KDM4E B2RXH2 2/20 0.47
NPC1 O15118 1/20 0.47
ALDH1A1 P00352 1/20 0.47
PKM P14618 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
GAPDH P04406 1/20 0.42
MAPT P10636 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14795367 0.86 FGFR1 (0.54) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL3378283 0.80 FGFR1 (0.63) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL14795440 0.80 FGFR1 (0.54) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL1052022 0.74 FGFR1 (0.66) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL1055142 0.74 FGFR1 (0.66) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL14796657 0.73 FGFR1 (0.62) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL14795940 0.73 FGFR1 (0.66) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL3918718 0.72 NPC1 (0.83) KDM4ENPC1ALDH1A1PKMRAB9A
SCHEMBL15910561 0.71 FGFR1 (0.58) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL15911026 0.70 FGFR1 (0.67) FGFR1PDGFRBKDRFLT1CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2762475-A1 Pharmaceutically acceptable salts of quinolinone compounds and their medical use Novartis Vaccines and Diagnostics, Inc. (US) 2014-08-06 EP disclosed
EP-2573079-A2 Benzimidazole quinolinones and uses thereof Novartis Vaccines and Diagnostics, Inc. (US) 2013-03-27 EP disclosed